Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/01/07 → 31/12/09 |
Funding
- National Health and Medical Research Council (NHMRC) (Australia): A$492,000.00
Anti-atherosclerotic effects of angiotensin fragments and non-AT1 receptors: Validation as innovative therapeutic targets.
- Widdop, Robert (Primary Chief Investigator (PCI))
- Drummond, Grant (Chief Investigator (CI))
- Schmidt, Harald (Chief Investigator (CI))
Project: Research